ClinConnect ClinConnect Logo
Search / Trial NCT03480165

The Efficacy of 20 mg Parecoxib as an Adjunct to 0.75% Ropivacaine in Supraclavicular Brachial Plexus Block for Upper Limb Surgery

Launched by UNIVERSITI SAINS MALAYSIA · Mar 20, 2018

Trial Information

Current as of May 13, 2025

Completed

Keywords

Randomized Controlled Trial Double Blind Parallel Group

ClinConnect Summary

Brachial plexus block (BPB) has enjoyed ubiquitous popularity for upper limb surgeries.There are a few common techniques for BPB and one of the most frequently-utilised one is supraclavicular BPB since it provides a quick-onset, efficient, safe and dense anaesthesia for surgical procedures that involve the proximal mid-humerus down to the distal hand. At present, most BPB techniques have been widely performed under ultrasound guidance to enhance the BPB's success rate and lessen its complications.

There are several adjunct drugs that can be mixed with local anaesthetics agents (e.g. ropiva...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. American Society of Anaesthesiology Physical Status Gred 1 and 2
  • 2. Expected duration of surgery is between 1 and 4 hours
  • Exclusion Criteria:
  • 1. Subjects who refused brachial plexus block
  • 2. Know allergies to parecoxib, other NSAID and anaesthetic agents
  • 3. Pregnancy
  • 4. Prior history of brachial plexus injury
  • 5. Chronic pain history which long term use of analgesic medications
  • 6. Coagulopathy
  • 7. Systemic or local infection at the injection site
  • 8. Known neuropathy affecting the limb which undergo the surgical procedures

About Universiti Sains Malaysia

Universiti Sains Malaysia (USM) is a leading research university in Malaysia, renowned for its commitment to advancing scientific knowledge and innovation in the healthcare sector. As a clinical trial sponsor, USM leverages its multidisciplinary expertise and state-of-the-art facilities to conduct rigorous research aimed at improving patient outcomes and addressing pressing health challenges. The university fosters collaboration among researchers, medical professionals, and industry partners, ensuring that its clinical trials are conducted with the highest ethical standards and scientific integrity. Through its dedication to excellence in research and education, USM plays a pivotal role in shaping the future of healthcare both locally and globally.

Locations

Kubang Kerian, Kelantan, Malaysia

Patients applied

0 patients applied

Trial Officials

Vivekananda Gunasekaran, MBBS

Principal Investigator

Universiti Sains Malaysia

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials